{"nctId":"NCT02007434","briefTitle":"Patient Experience Study of Deoxycholic Acid Injection","startDateStruct":{"date":"2013-12"},"conditions":["Moderate or Severe Submental Fullness"],"count":84,"armGroups":[{"label":"Paradigm 1 / Deoxycholic Acid Injection","type":"EXPERIMENTAL","interventionNames":["Drug: Deoxycholic Acid Injection","Other: Cold Compress"]},{"label":"Paradigm 1/ Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Other: Cold Compress"]},{"label":"Paradigm 2 / Deoxycholic Acid Injection","type":"EXPERIMENTAL","interventionNames":["Drug: Deoxycholic Acid Injection","Other: Cold Compress","Drug: Lidocaine / Epinephrine"]},{"label":"Paradigm 2 / Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Other: Cold Compress","Drug: Lidocaine / Epinephrine"]},{"label":"Paradigm 3 / Deoxycholic Acid Injection","type":"EXPERIMENTAL","interventionNames":["Drug: Deoxycholic Acid Injection","Other: Cold Compress","Drug: Lidocaine / Epinephrine","Drug: Loratadine","Drug: Ibuprofen"]},{"label":"Paradigm 3 / Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Other: Cold Compress","Drug: Lidocaine / Epinephrine","Drug: Loratadine","Drug: Ibuprofen"]},{"label":"Paradigm 4 / Deoxycholic Acid Injection","type":"EXPERIMENTAL","interventionNames":["Drug: Deoxycholic Acid Injection","Other: Cold Compress","Drug: Lidocaine / Epinephrine","Drug: Loratadine","Drug: Ibuprofen","Other: Compression Chin Strap"]},{"label":"Paradigm 4 / Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Other: Cold Compress","Drug: Lidocaine / Epinephrine","Drug: Loratadine","Drug: Ibuprofen","Other: Compression Chin Strap"]}],"interventions":[{"name":"Deoxycholic Acid Injection","otherNames":["ATX-101","Kybella"]},{"name":"Placebo","otherNames":[]},{"name":"Cold Compress","otherNames":[]},{"name":"Lidocaine / Epinephrine","otherNames":[]},{"name":"Loratadine","otherNames":[]},{"name":"Ibuprofen","otherNames":[]},{"name":"Compression Chin Strap","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Submental fat graded by the Investigator as 2 (moderate) or 3 (severe) using the Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) and graded by the subject as 2 (moderate amount) or 3 (large amount) using the Patient-Reported Submental Fat Rating Scale (PR-SMFRS)\n2. Dissatisfaction with the appearance of the submental area expressed by the subject as a rating of 0, 1, or 2 using the Subject Self Rating Scale (SSRS)\n3. History of stable body weight for at least 6 months and body mass index (BMI) of ≤ 40 kg/m².\n4. Acceptable skin laxity as determined by the investigator\n5. Agreement by the subject to refrain from making significant changes, in the documented judgment of the investigator, to his or her dietary or exercise habits during the course of the subject's participation.\n6. Agreement to forego any treatment or behavior (e.g., unshaven facial hair)\n7. Signed informed consent obtained before any study-specific procedure is performed.\n\nExclusion Criteria:\n\n1. No prior intervention for submental fullness or recent cosmetic procedure in the neck or chin area\n2. Absence of clinically significant health problems\n3. Body mass index \\> 40.0 kg/m² as determined prior to randomization.\n4. History of drug or alcohol abuse.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Pain Visual Analog Scale Scores","description":"Participants were provided with a scale 100 mm in length and were asked to mark the place on the line that best represents his or her pain associated with the area treated with study drug. The scale ranged from 0 (no pain) to 100 (most severe pain possible).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"0.0","spread":null},{"groupId":"OG003","value":"0.0","spread":null},{"groupId":"OG004","value":"0.0","spread":null},{"groupId":"OG005","value":"0.0","spread":null},{"groupId":"OG006","value":"0.0","spread":null},{"groupId":"OG007","value":"0.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Change From Baseline in Pain Assessment Using McGill Pain Questionnaire","description":"Participants rated 15 pain characteristics by using a number to signify how much of that specific type of pain they were experiencing using the Short-Form McGill Pain Questionnaire. The pain characteristic options included Throbbing, Shooting, Stabbing, Sharp, Cramping, Gnawing, Hot-burning, Aching, Heavy, Tender, Splitting, Tiring-exhausting, Sickening, Fearful, and Punishing- cruel. Participants assessed the intensity of each characteristic using the following score system: none (0), mild (1), moderate (2), and severe (3). In addition, present pain was assessed on a scale from 0 (no pain) to 5 (excruciating).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.1","spread":"0.25"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.1","spread":"0.25"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.1","spread":"0.25"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.1","spread":"0.25"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]}]},{"type":"PRIMARY","title":"Swelling Grading Scale Scores","description":"The following grading system was used for the assessment of swelling:\n\n* Swelling/edema absent (0)\n* Minimal swelling/edema contained within treatment area (1)\n* Modest swelling/edema contained within treatment area (2)\n* Substantial swelling/edema contained within treatment area (3)\n* Swelling/edema of the neck and face beyond the treatment area (4)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]}]},{"type":"PRIMARY","title":"Bruising Grading Scale Scores","description":"The following grading system was used for the assessment of bruising:\n\n* Bruising absent (0)\n* Bruising associated with 1 to 3 needle insertion points (1)\n* Bruising spreading beyond 4 or more individual needle insertion points but contained within the treatment area (2)\n* Bruising covering the entire treatment area but contained within the treatment area (3)\n* Bruising of the neck and face beyond the treatment area (4)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.0","spread":"0.00"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.0","spread":"0.00"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]}]},{"type":"PRIMARY","title":"Induration Grading Scale Scores","description":"The following grading system was used for the assessment of induration:\n\n* Induration absent to minimal (0)\n* Induration associated with at least approximately 30% of the treatment area (1)\n* Induration associated with greater than approximately 30% to at least 60% of the treatment area (2)\n* Induration covering the entire treatment area but contained within the treatment area (3)\n* Induration of the neck and face beyond the treatment area (4)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.00"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.1","spread":"0.25"},{"groupId":"OG003","value":"0.0","spread":"0.00"},{"groupId":"OG004","value":"0.0","spread":"0.00"},{"groupId":"OG005","value":"0.0","spread":"0.00"},{"groupId":"OG006","value":"0.1","spread":"0.32"},{"groupId":"OG007","value":"0.0","spread":"0.00"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Clinician-Reported Submental Fat Rating Scale (CR-SMFRS)","description":"The CR-SMFRS score is based on the investigator's clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0-4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme. A negative change from Baseline indicates improvement.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.6","spread":"0.50"},{"groupId":"OG001","value":"-0.7","spread":"0.58"},{"groupId":"OG002","value":"-0.6","spread":"0.63"},{"groupId":"OG003","value":"-0.8","spread":"0.96"},{"groupId":"OG004","value":"-0.4","spread":"0.50"},{"groupId":"OG005","value":"0.0","spread":"0.82"},{"groupId":"OG006","value":"-0.4","spread":"0.50"},{"groupId":"OG007","value":"-0.3","spread":"0.50"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Patient-Reported Submental Fat Rating Scale (PR-SMFRS)","description":"The PR-SMFRS is based on the participant's response to the question \"How much fat do you have under your chin right now?\" answered on a 5-point ordinal scale (0-4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat. A negative change from Baseline indicates improvement.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.2","spread":"0.75"},{"groupId":"OG001","value":"-0.7","spread":"1.15"},{"groupId":"OG002","value":"-0.9","spread":"0.72"},{"groupId":"OG003","value":"-0.5","spread":"1.29"},{"groupId":"OG004","value":"-0.8","spread":"0.86"},{"groupId":"OG005","value":"-0.8","spread":"0.50"},{"groupId":"OG006","value":"-0.7","spread":"0.57"},{"groupId":"OG007","value":"-0.5","spread":"0.58"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Subject Self Rating Scale (SSRS)","description":"The SSRS assesses participant's satisfaction with their appearance in association with the face and chin on a 7-point scale from 0 to 6: where 0 = Extremely dissatisfied, 1 = Dissatisfied, 2 = Slightly dissatisfied, 3 = Neither satisfied nor dissatisfied, 4 = Slightly satisfied, 5 = Satisfied and 6 = Extremely satisfied. A positive change from Baseline indicates improvement.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"1.84"},{"groupId":"OG001","value":"2.3","spread":"3.51"},{"groupId":"OG002","value":"3.2","spread":"1.56"},{"groupId":"OG003","value":"1.8","spread":"1.71"},{"groupId":"OG004","value":"2.3","spread":"1.95"},{"groupId":"OG005","value":"2.3","spread":"1.50"},{"groupId":"OG006","value":"2.4","spread":"1.38"},{"groupId":"OG007","value":"2.0","spread":"1.41"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Submental Skin Laxity Grades (SMSLG)","description":"Skin laxity assessment was based on clinical evaluation and palpation of the submental area on the following scale: 1 = no laxity; 2 = mild laxity; 3 = moderate laxity; 4 = severe laxity. A negative change from Baseline indicates improvement.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2","spread":"0.66"},{"groupId":"OG001","value":"0.0","spread":"0.00"},{"groupId":"OG002","value":"0.1","spread":"0.77"},{"groupId":"OG003","value":"0.5","spread":"0.58"},{"groupId":"OG004","value":"0.3","spread":"0.45"},{"groupId":"OG005","value":"0.5","spread":"0.58"},{"groupId":"OG006","value":"0.3","spread":"0.67"},{"groupId":"OG007","value":"0.3","spread":"0.50"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Submental Fat Thickness","description":"Submental thickness was measured using caliper devices.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.4","spread":"1.67"},{"groupId":"OG001","value":"-2.3","spread":"2.08"},{"groupId":"OG002","value":"-1.6","spread":"2.34"},{"groupId":"OG003","value":"-0.3","spread":"2.75"},{"groupId":"OG004","value":"-0.9","spread":"3.77"},{"groupId":"OG005","value":"-2.3","spread":"2.22"},{"groupId":"OG006","value":"-1.5","spread":"3.33"},{"groupId":"OG007","value":"-2.8","spread":"2.22"}]}]}]},{"type":"SECONDARY","title":"Patient Experience Questions","description":"Participants were asked to complete 3 patient experience questions, each answered as Yes or No:\n\nGiven your experience in this study:\n\n1. Would you recommend this procedure to a friend?\n2. Would you agree to receive additional treatments?\n3. Has the treatment you received in this study affected your normal activities?\n\nThe percentage of participants answering Yes on each question is reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"81","spread":null},{"groupId":"OG001","value":"33","spread":null},{"groupId":"OG002","value":"81","spread":null},{"groupId":"OG003","value":"50","spread":null},{"groupId":"OG004","value":"94","spread":null},{"groupId":"OG005","value":"100","spread":null},{"groupId":"OG006","value":"72","spread":null},{"groupId":"OG007","value":"75","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"81","spread":null},{"groupId":"OG001","value":"67","spread":null},{"groupId":"OG002","value":"88","spread":null},{"groupId":"OG003","value":"50","spread":null},{"groupId":"OG004","value":"94","spread":null},{"groupId":"OG005","value":"100","spread":null},{"groupId":"OG006","value":"78","spread":null},{"groupId":"OG007","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"0","spread":null},{"groupId":"OG002","value":"13","spread":null},{"groupId":"OG003","value":"0","spread":null},{"groupId":"OG004","value":"19","spread":null},{"groupId":"OG005","value":"0","spread":null},{"groupId":"OG006","value":"11","spread":null},{"groupId":"OG007","value":"25","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":["Injection site oedema","Injection site haemorrhage","Injection site pain","Injection site induration","Injection site discomfort"]}}}